Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-22
1989-07-18
Ceperley, Mary E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514278, 514318, 514323, 514339, 514416, 546 15, 546201, 546273, 548410, 548465, 548472, A61K 3140, C07D20946
Patent
active
048494410
ABSTRACT:
Isoindolin-1-one compounds represented by the following formula (I); ##STR1## {wherein n represents an integer of 1 to 6; m represents 0 or 1; R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen or lower alkyl, and when m is 1, R.sub.1 and one of R.sub.2 and R.sub.3 may form a five-membered or six-membered ring over N atom; X represents hydrogen or hydroxy; Ar represents naphthyl, pyridyl or substituted phenyl represented by the formula (II); Ar and X may form a lactone ring; ##STR2## [wherein Y represents carboxyl, lower alkoxycarbonyl, carbamoyl, N,N-lower alkyl-substituted carbamoyl or amino represented by the formula (III): ##STR3## (wherein R.sub.6 and R.sub.7 are each independently hydrogen, lower alkyl or lower alkanoyl); R.sub.4 and R.sub.5 are each independently hydrogen, lower alkyl, cyano or halogen]} or a pharmaceutically acceptable acid addition salt or metal salt thereof have an excellent antiarrhythmic activity.
REFERENCES:
patent: 3091568 (1963-05-01), Bub
patent: 3445476 (1969-05-01), Sulkowski et al.
patent: 3538113 (1970-11-01), Houlihan
patent: 3849570 (1974-11-01), Raschack et al.
patent: 3885037 (1975-05-01), Sulkowski
patent: 4087541 (1978-05-01), Eberlein et al.
A. Knoll, Chem. Abstracts, vol. 58, No. 1412h (1962).
J. Sprague et al., Chem. Abstracts, vol. 68, No. 114434d (1968).
Arch. Int. Pharmacodyn. Ther., 185, 47 (1970); C. Hanna "Gitan, 2-(.beta.-Diethylaminoethyl)-3-Phenylphthalimidine Phosphate an Antitussive Agent".
Chemical Abstracts, vol. 76, No. 1, 1,18, Jan. 3, 1972, Columbus, Ohio, U.S.A. and related Sulkowski, et al. "Tetrahydropyrimidinyl- and Imidazolinylphenyl Ketones as Antidepressants and Diuretics", p. 346, col. 1, 2, Abstract-No. 3 893y.
Chemical Abstracts, vol. 83, No. 23,1,18, Dec. 8, 1975, Columbus, Ohio, U.S.A. and related Sulkowski, Theodore S. "Producing Anorexia Using Imidazolinyl Phenyl Carbonyl Compounds, Their Acid Addition Salts and Related Compounds", p. 473, col. 2, Abst. No. 193 362q.
Chemical Abstracts, vol. 72, No. 19, May 11, 1970, Columbus, Ohio, U.S.A. and related Houlihan, William J., "2-(2-Amino-ethyl)-3-(substitutedphenyl)-phthalimidines", p. 354, col. 1, Abstract No. 100 505y.
Chemical Abstracts, vol. 87, No. 1, 1,18 Jul. 4, 1977, Columbus, Ohio, U.S.A. and related Thomae, Dr. Karl, GmbH "Substituted arylalkylamines", p. 630, col. 1, Abstract-No. 23 039e.
Kubo Kazuhiro
Nito Masaaki
Obase Hiroyuki
Oiji Yoshimasa
Okazaki Kei
Ceperley Mary E.
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
Isoindolin-1-one derivative and antiarrhythmic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoindolin-1-one derivative and antiarrhythmic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoindolin-1-one derivative and antiarrhythmic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-172648